Clin2
NCT06831500Possibly a fitRecruiting

Study on carbidopa/levodopa ratio for low blood pressure in MSA-P and Parkinson's

Multi-system Atrophy - Parkinsonian TypeOrthostatic Hypotension, DysautonomicParkinson Disease

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests whether adjusting the ratio of carbidopa and levodopa (medications used for Parkinson's) can help reduce dizziness or fainting from low blood pressure when standing up, in people with Multiple System Atrophy (Parkinsonian type) or Parkinson's disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
36 people
Ages
Any age
Study type
Interventional

Who can take part

  • You are between 18 and 79 years old.
  • You have Multiple System Atrophy (parkinsonian type) or Parkinson's disease with symptoms of low blood pressure when standing (like dizziness or feeling faint).
  • You are currently taking levodopa combined with carbidopa or benserazide.
  • You are able to stop taking your regular levodopa medication overnight (at least 12 hours) and your extended-release dose at least 24 hours before the test.
  • You do not have severe heart failure, dementia, or significant memory problems that make it hard to understand the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07139756Not yet recruiting
Parkinson's and blood pressure study with MRI

This study uses MRI to understand how blood pressure is controlled in people with Parkinson's disease who have orthostatic hypotension (a drop in blood pressure when standing). It may help find better treatments for this common symptom.

Lausanne, Canton of Vaud
NCT06920134Recruiting
Spinal cord stimulation for blood pressure in Parkinson's disease

This trial tests if electrical stimulation of the spinal cord can help manage blood pressure drops (orthostatic hypotension) in people with Parkinson's and related conditions. It might make daily activities like standing and walking easier.

Lausanne, Canton of Vaud
NCT04735627Recruiting
Real-time monitoring of levodopa levels in Parkinson’s

This study checks whether measuring levodopa (a Parkinson medicine) in real time can help better understand Parkinson medication effects. You may be asked to wear/perform study monitoring while taking your usual carbidopa/levodopa tablets.

San Diego, California
NCT02897063Recruiting· Phase 1
Test medicines for low blood pressure in nerve-related disorders

This early (Phase 1) study tests whether midodrine and droxidopa can improve blood-flow pooling in the belly in people with nerve problems that affect blood pressure when standing. It’s looking at safety and how the body responds, which may help reduce dizziness or fainting for some participants.

Nashville, Tennessee
NCT05400174Recruiting
How blood pressure changes affect thinking and brain flow in Parkinson’s

This study measures how your blood pressure affects thinking skills and how blood flows in the brain in people with Parkinson’s. It may help researchers understand what blood-pressure changes could mean for cognition in Parkinson’s.

San Diego, California
NCT07748715Not yet recruiting
Brain dopamine biomarker study for Parkinson's disease

This study uses a special test to look at dopamine levels in the brain of people with Parkinson's disease. It may help doctors understand the disease better and could lead to better treatments.

Hear when a new Orthostatic Hypotension, Dysautonomic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.